Skip to main content

Full text of "USPTO Patents Application 09848616"

See other formats


IN THE UNITED STATES PATENT AND TRADEMARK OFHC 



In re application of: 
Sebbel et al. 

Appl. No. 09/848,616 y 

Filed: May 4, 2001 

For: Molecular Antigen Array 




Confirmation No. 6018 
Art Unit: 1648 
Examiner: Mosher, M. 
Atty. Docket: 1700.01 80002/JAG/BJD 



Reply To Requirement for Election of Species 

Commissioner for Patents D CT p- 1 \/ F D 

Washington, D.C. 2023 1 

DEC 0 3 2002 

Sir: TECH CENTER 1600/2900 

In reply to the Office Action dated August 30, 2002, requesting an election of one 
species to prosecute in the above-referenced patent application. Applicants hereby 
provisionally elect to prosecute species 3, Hepatitis B particle with covalently associated 
antigen, and the sequence of claim 28 having at least 90% sequence identity to SEQ ID 
NO: 158. This election is made without traverse, and without prejudice to or disclaimer 
of the other claims, species or inventions disclosed. 

Reconsideration and withdrawal of the Requirement for Election of Species, and 
consideration and allowance of all pending claims, are respectfully requested. 

It is not believed that extensions of time are required, beyond those that may 
otherwise be provided for in accompanying documents. However, if additional 
extensions of time are necessary to prevent abandonment of this application, then such 
extensions of time are hereby petitioned under 37 C.F.R. ยง 1, 136(a), and any fees 



-2- 



Sebbel et al 
Appl. No. 09/848,616 



required therefor are hereby authorized to be charged to our Deposit Account No. 
19-0036. 

Respectfully submitted, 

Sterne, Kessler, Goldstein & Fox p.l.l.c. 

Brian J. Del Buono 
Attorney for Applicants 
Registration No. 42,473 

Date: K)W^ 

1 100 New York Avenue, N.W. 
Suite 600 

Washington, D.C. 20005-3934 
(202) 371-2600 



::ODMA\MHODMA\SKGF_DC 1 :79 1 22; 1 
SKGFrev 1/26/01 mac